About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
SK Bioscience image

SK Bioscience

Summary
History
Mission
Vision
References
Summaryarrow
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.
Historyarrow

SK Biotekhno Co. was established in 1991 as the first biopharmaceutical company in South Korea. It was founded as part of a national effort to promote the biotechnology industry and to provide high-quality biopharmaceutical products to the public. Since then, it has become the world's leading innovator of biotech drugs and a leader in the sector

Missionarrow
SK Biotekhno’s mission is to develop research on life sciences, create innovative biopharmaceuticals, and create a better life for all
Visionarrow
SK Biotekhno’s vision is to be the best biopharmaceutical company in the world, creating innovative therapies and improving healthcare outcomes.
Referencesarrow

https://in.investing.com/equities/sk-bioscience-co

https://finance.yahoo.com/quote/302440.KS/profile?p=302440.KS

https://www.crunchbase.com/organization/sk-bioscience

https://www.skbioscience.co.kr

Share

Leadership team
M
Mr. Jae-Yong Ahn (CEO, Pres & Director)
M
Ms. SookMi Hwang (Head of Global Regulatory Affairs)
M
Mr. Hoon Kim (CTO & Exec. Director)
Products / Services
Biopharma, Biotechnology, Pharmaceutical
Number of Employees
1,000 - 20,000
Address
Seongnam, Kyonggi-do, South Korea
Established
2018-01-01
Net Income
S_100M_500M
Revenue
500M - 1B
Traded as
KRX:302440
Website
https://www.skbioscience.co.kr
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo